A venture capital firm formed by a founder of one of the first companies to win Food and Drug Administration approval for a cell therapy for cancer closed a new fund worth more than half of $1 billion.
{iframe}https://medcitynews.com/2019/08/kite-pharma-founders-venture-capital-firm-closes-new-600m-fund/{/iframe}